相关实验视频

Updated: Jul 4, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

鉴定和验证STAT4作为急性髓性白血病的预后生物标志物

Chenyu Li^1,2, Jingyuan Zhao³, Bingyu Kang^1,2

¹Department of Pharmacy, The First Affiliated Hospital of Dalian Medical University, Dalian, China.

Bioscience reports

|January 31, 2024

概括

这项研究确定STAT4是影响急性髓性白血病 (AML) 免疫逃避的关键基因. STAT4可以作为AML的预后生物标志物,影响患者的治疗结果和复发.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
遗传学遗传学是一种遗传学.

背景情况:

急性髓性白血病 (AML) 可以逃避免疫监测.
识别影响瘤免疫力和预后的基因对于AML管理至关重要.

研究的目的:

确定AML中影响瘤免疫力和患者生存的关键基因.
通过使用公共数据集验证AML潜在的预后生物标志物.

主要方法:

查癌症基因组图谱 (TCGA) 免疫相关的转录因子 (TFs) 影响生存.
使用基因表达综合 (GEO) 数据验证TF对患者生存的影响.
建立预后特征并分析AML患者样本中的基因表达.

主要成果:

开发了一种四TF预后特征,与调控性T细胞 (Treg) 评分相关.
STAT4表达与异常细胞比例和AML复发正相关.
STAT4沉默降低了HL60细胞的增殖,表明它在AML进展中的作用.

结论:

STAT4是急性髓性白血病的潜在预后生物标志物.
在AML免疫逃避和进展中,STAT4起着重要作用.
作为AML的诊断和预后标志物,STAT4值得进一步研究.

关键词:

在AML,AML就是AML.在STAT4中,我们使用了STAT4.这就是Treg Treg.预后生物标志物预后生物标志物转录因子的转录因子

更多相关视频

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...